Home | Contact | Tr
     ISSN 2149-2042
     e-ISSN 2149-4606
 
 
 
Volume : 33 Issue : 2 Year : 2018



Current Issue Archive Popular Articles Ahead of Print




















 
  Quick Search



Author Guidlines

MMJ publishes original articles on clinical and experimental research related to any area of medicine. Editorials, letter to the editor, review articles, case reports and technical note on clinical observations may also be considered. By submitting a manuscript to this journal, authors accept that their manuscript may be screened for plagiarism against previously published works. Processing and publication are FREE of charge. No fees are requested from the authors at any point throughout the evaluation and publication process. One of the main goals of the journal is to provide global researchers with a free publishing platform. Anyone can use the articles as long as the credit is given to the author and citation to the original source. It is available to reach the articles by search engines, websites, blogs and other digital platforms.

POLICY OF SCREENING FOR PLAGIARISM
The manuscripts are scanned by the Publisher’s Office using the iThenticate program for determination of plagiarism and non-ethical situations. The corresponding author will receive an e-mail that informs the status of the manuscript at any step of reviewing and publishing process.

MANUSCRIPT FORMAT AND STYLE
Manuscripts should be written in Turkish or in English. If the manuscript is in Turkish, it must also include English abstract and Keywords. Papers should be typed in 12-point typescript and double-spaced throughout the text including tables and references with wide margins (2.5 cm) on each side of a standard A4 paper. The manuscript should include the following: (i) title page, (ii) abstract, (iii) main text (introduction, materials and methods, results, discussion), (iv) references, (v) figure legends, (vi) tables, (vii) figures.

TITLE PAGE
The first page should contain: a title of the paper, suggested running headline of not more than 30 characters (including both letters and spaces) and author’s name, department, institution, city and, country. Authors that work different department or center should be indicated by superscript numbers. The title page should carry the name and address of the author to whom correspondence. Telephone and fax numbers (as well as an e-mail address if available) should also be given. The corresponding author will receive an e-mail alert containing a link to a website. Therefore, a working e-mail address must be provided for the corresponding author.

ABSTRACT
Abstract word count must be between 150 and 250. The subtitles are not needed. But, it should be covered;

OBJECTÝVES
Give a short information about the studied topics and clear statement of the main aim of the study and the main hypothesis

METHODS
Describe the setting of the study. Abstract in English is necessary for the manuscript written in Turkish.

RESULTS
Give the main results of the study.

CONCLUSIONS
State the primary conclusions of the study and their clinical implications. Suggest areas for further research, if appropriate. Abbreviations: Abbreviations should be standard. Any nonstandard abbreviations should be defined in the text when first used. Tables and legends: Tables and legends should be typed on separate pages at the end of the manuscript. Any explanation should be defined as a footnote, not in the legend line.

ILLUSTRATIONS
All illustrations, artworks and figures should be original. It is the authors’ responsibility to obtain necessary permissions for any material with copyright. Illustrations, figures and graphics should be prepared in tiff format with a minimum resolution of 300 dpi. They should be clear, sharp, easily readable and legible. Illustrations must be cited in consecutive numerical order in the text. The staining method and the magnification rate should be indicated in microscopic illustrations (e.g. H&E, x400). Submitted photographs, figures and graphics should be of professional quality. Legends for the figures should be typed double-spaced on a separate page. They must be concise and represent summaries of findings. Authors should retain one copy of original artwork.

KEYWORDS

The authors have to list at least three, but no more than five keywords below the abstract. Preferably use terms from the ‘Medical Subject Headings’ (http:// www.nlm.nih.gov/mesh/MBrowser.html) list from Index Medicus. If the manuscript is written in Turkish, it is recommended to select the keywords from ‘Türkiye Bilim Terimleri’ (http://www.bilimterimleri.com).

Acknowledgements
Financial support, technical and other assistance of importance for the study may be acknowledged before references.

References

Number references consecutively in the order in which they are first mentioned in the text. Identify references in text, tables and captions by Arabic numerals in [square] brackets. Use the references form adopted by the US National Library of Medicine. Titles of journals should be abbreviated according to the style used in Index Medicus. In the list, reference can be made by only published or accepted articles.Number of references must be truncated by 15, 30 and 40 references for case report, original investigation and review article, respectively.

For journal articles
Altundag O, Gullu I, Altundag K, et al. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients. Head Neck 2005;27:15-21

Journal article in press

Cengiz M, Ozyigit G, Yazici G, et al. Salvage Reirradiaton with Stereotactic Body Radiotherapy for Locally Recurrent Head-and-Neck Tumors. Int J Radiat Oncol Biol Phys 2010 Jul 31. doi:10.1016/j.ijrobp.2010.04.027

For book references
Chao KSC, Ozyigit G. Intensity Modulated Radiation Therapy for Head&Neck Cancer. 1st edition. Philadelphia, Lippincott Williams & Wilkins, 2003: 34-36.

Book chapters

Ozyigit G, Beyzadeoglu M, Ebruli C. Genitourinary system cancers. In: Basic Radiation Oncology. Beyzadeoglu M, Ozyigit G, Ebruli C (eds). 1st edition. Springer-Verlag Berlin, Heidelberg, 2010: 363-410.

For congress presentations
Appelbaum FR, Gilliland DG, Tallman MS. The biology and treatment of acute myeloid leukemia. In: 40th Annual Meeting of the American Society of Hematology Education Book. McArthur JR, Schechter GP, Schrier SL (eds). December 4-8, 1998, Miami Beach, Florida, 1998: 10-13.

Congress abstracts
Ayhan A, Yasui W, Yokozaki H, Tahara E. Gastrointestinal karsinomlarda bcl-2 ekspresyonu ve gen degisiklikleri. XII. National Cancer Congress, Antalya, April 23-26, 1997: P307.

Thesis

Güllü IH. Mide kanserli hastalarda 5-florourasil, adriamisin, mitomisin kombine kemoterapisinin degerlendirilmesi. Hacettepe University Faculty of Medicine, Oncology Institute, Medical Oncology Department Graduate Thesis, Ankara, 1992.

Internet resources
http://www.cancer.gov/cancertopics/types/bladder (Access date: 12/14/208). In case of use of a previously published table, figure or illustration, reference of the material must be cited in reference list.

ACCEPTED ARTICLES

Accepted Articles should be designed by the authors. Designed Articles are published in online issue without having been copy-edited. Medeniyet medical journal (MMJ) cannot be held responsible for errors or consequences arising from the use of information contained in these articles; nor do the views and opinions. Accepted Articles appear in PDF format.

ETHICAL GUIDELINES
Submission is considered on the conditions that papers are previously unpublished, and are not offered simultaneously elsewhere; that authors have read and approved the content, and all authors have also declared all competing interests; and that the work complies with the Ethical Approval and has been conducted under internationally accepted ethical standards. If ethical misconduct is suspected, the Editorial Board will act in accordance with the relevant international rules of publication ethics (i.e., COPE guidelines). To verify the originality of content submitted to MMJ, iThenticate is used to check submissions against previous publications.

HUMAN AND ANIMAL RIGHTS
The policy of the journal is respectful of the Human and Animal Rights. If the work involves the use of human or animal subjects, an approval of research protocols by an ethics committee in accordance with international agreements (“WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects, October 2013, Fortaleza, Brazil”, "Guide for the care and use of laboratory animals, 8th edition, 2011" and/or “International Guiding Principles for Biomedical Research Involving Animals, 2012”) is required for all research studies. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed. If the submitted manuscript does not include ethics committee approval, it will be reviewed according to COPE's guideline (Guidance for Editors: Research, Audit and Service Evaluations).

SUBMISSION OF MANUSCRIPTS
All manuscripts should be written in English or Turkish language and prepared in Microsoft Word format. Language editing should also be appropriate for an academic journal. Tables, figures and pictures should be embedded in appropriate part of manuscript. The SI system must be used. To be considered for publication, the author should also provide suggestions for at least two reviewers. MMJ will evaluate manuscripts submitted via journal’s online manuscript submission system (www.medeniyetmedicaljournal.org). Our journal now uses an online submission and peer review system in ScopeMed (www.scopemed.org). This can bring a number of advantages to authors, referees, the editorial office and the publishing process in general. To submit online a paper to MMJ, you can access ScopeMed Online Submission System by clicking http://my.ejmanager.com/ms/. In case of any problem or technical error to access the online submission system, please contact directly to the Editor by e-mail (editor@medeniyetmedicaljournal.org).

COVER LETTER
Corresponding author must give signed consent to publication in a covering letter including the following information.

• A statement that the manuscript has not been published elsewhere, and that, if accepted in MMJ will not be republished in any other journal in the same or similar form. Written permission must be obtained from the copyright holder for reproduction of figures published elsewhere.
• A statement of financial or other relationships that might lead to a conflict of interest.
• A statement that the manuscript has been read and approved by all authors.

COPYRIGHT
When manuscript is submitted to MMJ, the author(s) grant(s) to the Publisher exclusive first publication rights in website and press, and further grant(s) a nonexclusive license for other uses of the Work for the duration of its copyright in all languages, throughout the world, in all media. The Publisher shall include a notice in the Work saying “© [Author’s Name]. Readers of this article may copy it without the copyright owner’s permission, if the author and publisher are acknowledged in the copy and copy is used for educational, not-for-profit purposes.” Prior to acceptance all articles undergo peer-review process and will be accepted or rejected based on their own merit. All pages (including references, tables and their captions, figure captions and [where possible] figures) should be saved in a single electronic file.


 

  Copyright © 2015 MEDJ All Rights Reserved